Summary: In a recent article, Klaus Steger explores the potential dangers associated with the next generation of RNA-based vaccines containing self-amplifying RNA (saRNA). While saRNA replicates itself, offering the promise of increased antigen production with just one shot, Steger raises concerns about its genetic modification and the implications for our immune system. The article delves into the differences between saRNA and modified RNA (modRNA), highlighting the instability of mRNA and the potential for adverse effects. Additionally, Steger questions the move from linear to circular saRNA and its impact on immune tolerance. The piece concludes by criticizing the classification of RNA-based injections as vaccines rather than gene therapy products, emphasizing the need for careful consideration and ethical standards in the development and approval of such technologies.
November 29, 2023